Finance

Lists
SKYE:NASDAQ
Skye Bioscience Inc
$0.42
-17.23%
(-0.086) 1D
$0.42
+1.18% (+0.0049)
After hours
Closed: Aug 17, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SKYE...
Open
$0.57
High
$0.59
Low
$0.41
Mkt. cap
14.63M
Avg. vol.
350.19K
Volume
0.00
52-wk high
$4.99
52-wk low
$0.30
EPS
-$1.45
Beta
2.97
Shares outstanding
35.14M
No. of employees
2
Open
$0.57
High
$0.59
Low
$0.41
Mkt. cap
14.63M
Avg. vol.
350.19K
Volume
0.00
52-wk high
$4.99
52-wk low
$0.30
EPS
-$1.45
Beta
2.97
Shares outstanding
35.14M
No. of employees
2
News stories
From web sources and news partners
About Skye Bioscience Inc
CEO-
Employees2
Founded2011
Headquarters-
SectorBiotechnology
Websiteskyebioscience.com
Analyst ratings
Based on 1 analyst giving stock ratings to SKYE in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for SKYE in the last 3 months
Highest
Current $0.42
$20.00 (+4,718.12%)
Average
$20.00 (+4,718.12%)
Lowest
$20.00 (+4,718.12%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ananda Ghosh
H.C. Wainwright
Buy
Maintained
$20.00
+4,718.1%
05/21/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
$6.00
+1,345.4%
05/12/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
05/12/2026
Jay Olson
Oppenheimer
Buy
Maintained
$10.00
+2,309.1%
03/11/2026
Kristen Kluska
Cantor Fitzgerald
Hold
Maintained
$2.00
+381.8%
03/10/2026
Albert Lowe
Craig-Hallum
Hold
Maintained
-
-
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9.36M
11.47M
7.94M
3.94M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.91M
3.43M
4.74M
3.87M
Operating expense
13.26M
14.90M
12.67M
7.81M
Total operating expenses
13.26M
14.90M
12.67M
7.81M
Operating income
-13.26M
-14.90M
-12.67M
-7.81M
Other non operating income
-
-502.00
-2.41K
-
EBT including unusual items
-12.75M
-14.44M
-12.51M
-10.78M
EBT excluding unusual items
-12.85M
-14.62M
-12.51M
-7.71M
Income tax expense
-
-
-
3.40K
Effective tax rate
-
-
-
-0.03%
Other operating expenses
-
-
-
-
Net income
-12.75M
-14.44M
-12.51M
-10.79M
Net profit margin
-
-
-
-
Earnings per share
-0.32
-0.37
-0.32
-0.19
Interest and investment income
418.47K
274.10K
169.62K
103.21K
Interest expense
-
-
-2.20K
-3.30K
Net interest expenses
418.47K
274.10K
167.42K
99.91K
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.09M
-14.72M
-12.50M
-7.65M
Gain or loss from assets sale
-91.40K
-179.99K
7.62K
411.46K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps